184 related articles for article (PubMed ID: 18032029)
1. NK cell-mediated immune response against cancer.
Moretta L
Surg Oncol; 2007 Dec; 16 Suppl 1():S3-5. PubMed ID: 18032029
[TBL] [Abstract][Full Text] [Related]
2. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
Moretta A; Locatelli F; Moretta L
Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
[TBL] [Abstract][Full Text] [Related]
3. NK cells: a lesson from mismatched hematopoietic transplantation.
Velardi A; Ruggeri L; Alessandro ; Moretta ; Moretta L
Trends Immunol; 2002 Sep; 23(9):438-44. PubMed ID: 12200065
[TBL] [Abstract][Full Text] [Related]
4. Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias.
Moretta L; Locatelli F; Pende D; Mingari MC; Moretta A
Tissue Antigens; 2010 Feb; 75(2):103-9. PubMed ID: 20002610
[TBL] [Abstract][Full Text] [Related]
5. Alloreactive natural killer cells in targeting high-risk leukaemias.
Moretta L; Locatelli F; Moretta A
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii39-43. PubMed ID: 19022812
[TBL] [Abstract][Full Text] [Related]
6. Human NK receptors: from the molecules to the therapy of high risk leukemias.
Moretta L; Locatelli F; Pende D; Sivori S; Falco M; Bottino C; Mingari MC; Moretta A
FEBS Lett; 2011 Jun; 585(11):1563-7. PubMed ID: 21554879
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells: biology and clinical use in cancer therapy.
Hallett WH; Murphy WJ
Cell Mol Immunol; 2004 Feb; 1(1):12-21. PubMed ID: 16212916
[TBL] [Abstract][Full Text] [Related]
8. Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality?
Nguyen S; Béziat V; Roos-Weil D; Vieillard V
J Innate Immun; 2011; 3(4):383-94. PubMed ID: 21411973
[TBL] [Abstract][Full Text] [Related]
9. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
10. Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.
Passweg JR; Koehl U; Uharek L; Meyer-Monard S; Tichelli A
Best Pract Res Clin Haematol; 2006; 19(4):811-24. PubMed ID: 16997185
[TBL] [Abstract][Full Text] [Related]
11. The immunobiology of natural killer cells and bone marrow allograft rejection.
Barao I; Murphy WJ
Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
[TBL] [Abstract][Full Text] [Related]
12. Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference.
Locatelli F; Pende D; Maccario R; Mingari MC; Moretta A; Moretta L
Clin Immunol; 2009 Nov; 133(2):171-8. PubMed ID: 19481979
[TBL] [Abstract][Full Text] [Related]
13. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells--new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation.
Patil S; Schwarer T
Intern Med J; 2009 Oct; 39(10):639-47. PubMed ID: 19686544
[TBL] [Abstract][Full Text] [Related]
15. Development of natural killer cells from hematopoietic stem cells.
Yoon SR; Chung JW; Choi I
Mol Cells; 2007 Aug; 24(1):1-8. PubMed ID: 17846493
[TBL] [Abstract][Full Text] [Related]
16. Use of natural killer cells in hematopoetic stem cell transplantation.
Passweg JR; Stern M; Koehl U; Uharek L; Tichelli A
Bone Marrow Transplant; 2005 Apr; 35(7):637-43. PubMed ID: 15654351
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
Liu YP; Li Z; Nador RG; Strober S
Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer.
Ruggeri L; Mancusi A; Capanni M; Martelli MF; Velardi A
Curr Opin Immunol; 2005 Apr; 17(2):211-7. PubMed ID: 15766683
[TBL] [Abstract][Full Text] [Related]
19. Role of KIRs and KIR ligands in hematopoietic transplantation.
Velardi A
Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
[TBL] [Abstract][Full Text] [Related]
20. [Role of NK cell receptor-expressing cells in the regulation of GVHD and GVL].
Tanaka J
Rinsho Ketsueki; 2008 Aug; 49(8):598-606. PubMed ID: 18800608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
